Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1

Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors

(2011) Wiem Lassoued et al.   CANCER BIOLOGY & THERAPY

Engagement of Renin-Angiotensin System in Prostate Cancer

(2011) H. Uemura et al.   CURRENT CANCER DRUG TARGETS

Angiotensin-(1-7) Reduces Fibrosis in Orthotopic Breast Tumors

(2010) K. L. Cook et al.   CANCER RESEARCH

Evading tumor evasion: Current concepts and perspectives of anti-angiogenic cancer therapy

(2010) Amir Abdollahi et al.   DRUG RESISTANCE UPDATES

Mechanisms of resistance to antiangiogenesis therapy

(2010) Faisal Azam et al.   EUROPEAN JOURNAL OF CANCER

Angiogenesis inhibitors in the treatment of prostate cancer

(2010) Clara Hwang et al.   Journal of Hematology & Oncology

Clinical Applications of VEGF-Trap (Aflibercept) in Cancer Treatment

(2010) Li-Song Teng et al.   Journal of the Chinese Medical Association

Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells

(2010) Koji Hoshino et al.   PROSTATE

Novel Targeted Therapies for Prostate Cancer

(2010) Robyn J. Macfarlane et al.   UROLOGIC CLINICS OF NORTH AMERICA

Phase II study of sunitinib in men with advanced prostate cancer

(2009) M. Dror Michaelson et al.   ANNALS OF ONCOLOGY

Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited

(2009) Sonja Loges et al.   CANCER CELL

Phase I and Pharmacokinetic Study of Angiotensin-(1-7), an Endogenous Antiangiogenic Hormone

(2009) W. J. Petty et al.   CLINICAL CANCER RESEARCH

Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis

(2009) Masaru Iwai et al.   HYPERTENSION RESEARCH

Reinventing the ACE inhibitors: some old and new implications of ACE inhibition

(2009) Kashif Hanif et al.   HYPERTENSION RESEARCH

Angiotensin inhibition and malignancies: a review

(2009) T Rosenthal et al.   JOURNAL OF HUMAN HYPERTENSION

Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor

(2009) D. R. Soto-Pantoja et al.   MOLECULAR CANCER THERAPEUTICS

The renin-angiotensin system and malignancy

(2008) E. I. Ager et al.   CARCINOGENESIS

Angiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives

(2008) Dilek Iusuf et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Renin-angiotensin system revisited

(2008) F. Fyhrquist et al.   JOURNAL OF INTERNAL MEDICINE

New angiotensins

(2008) Jasmina Varagic et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Role of the renin–angiotensin system in prostate cancer

(2008) L. Chow et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY